Senate Aide Advises FDA Dialogue, Not Legislation, To Obtain User Fee Relief
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers seeking to revise CDRH performance goals and user fee collection targets are unlikely to find a suitable vehicle in MDUFMA "trigger-fix" legislation this fall